Superluminal Medicines
About:
Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.
Website: https://www.superluminalrx.com
Top Investors: NVIDIA, Eli Lilly, Insight Partners, Gaingels, Cooley
Description:
Superluminal Medicines is a generative biological and chemical company accelerating new possibilities in drug discovery and development. Its platform quickly creates candidate-ready compounds using a comprehensive combination of deep biology and chemistry expertise, machine learning, and proprietary big data infrastructure. They leverage cutting-edge computational and machine-learning techniques to accelerate identifying and optimizing novel drug candidates. Their approach combines high-throughput experimental data with advanced algorithms to uncover therapeutic compounds faster and more efficiently than traditional methods.
$153M
$1M to $10M
Boston, Massachusetts, United States
2022-01-01
Ajay Yekkirala, Cony D'Cruz
1-10
2024-09-09
Private
© 2025 bioDAO.ai